AzPA Pharmacy Flash

• How pharmacists can make an impact when treating dedifferentiated liposarcoma with brigimadlin
  Sarcoma, a rare type of soft tissue cancer, is primarily treated with surgery and systemic chemotherapy. Liposarcoma, a subtype of STS, accounts for 20% of adult cases. Treatment options include doxorubicin, gemcitabine, trabectedin, eribulin, pazopanib and palbociclib.
• Study identifies top ten priorities for future research on reducing and stopping psychiatric medication
  A study by Trinity College Dublin researchers has identified ten priorities for future research on reducing and stopping psychiatric medicines. The findings, based on stakeholder engagement, aim to guide future research and improve the health and well-being of individuals prescribed psychiatric medication.
• An integrated approach to optimizing specialty pharmacy and accelerating performance
  Specialty medications are expected to account for 65% of drug spending by 2025, necessitating strategic optimization across integrated channels. With rising prescription drug costs and staffing shortages, manual processes and outdated technology are affecting specialty pharmacy performance.